MHRA (UK)
OTHER
Nova Biomedical StatStrip ketone test strips: risk of disruption to blood ketone testing due to quality-control failures and supply interruption DSI/2026/013
Published: 10/9/2026Detected: 10/9/2026
Summary preview
Initiates regulatory action addressing quality-control failures in specified Nova Biomedical StatStrip ketone test strip lots that have led to a recall and may disrupt blood ketone testing availability.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
#MHRA
#medical device recall
#in vitro diagnostic
#blood ketone testing
#quality-control failure
Official Source Document Source Verified
Access the original document directly from MHRA.
More from MHRA (UK)
- Field Safety Notices for October 202610/9/2026
- Field Safety Notices: 8 -12 June 202610/9/2026
- Field Safety Notices: 28 September 2026 to 2 October 202610/9/2026
- Class 3 Medicines Recall: Norgine Limited, MOVICOL Plain 13.7g powder for oral solution, EL(26)A/4110/5/2026
- Class 4 Medicines Defect Notification: Neuraxpharm UK Limited, Levetiracetam Neuraxpharm granules for oral solution in sachet, EL(26)A/4010/1/2026